Medlab: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medlab
Largest movements
- Cash -€1.9m
down €1.9m (-76.2%), from €2.4m to €578,941
mainly Current investments (-€1.2m) and Contributions, distributions and other (-€1.0m)
- Current investments +€1.2m
up €1.2m, from €0 to €1.2m
- Receivables within one year -€28,552
down €28,552 (-99.0%), from €28,833 to €281
of which Trade receivables: -€23,838
- Reserves -€436,149
down €436,149 (-53.0%), from €822,275 to €386,126
- Other debts -€191,013
down €191,013 (-13.5%), from €1.4m to €1.2m
- Financial income -€60,383
down €60,383 (-83.8%), from €72,013 to €11,630
- Gross operating margin +€22,505
up €22,505 (+2.3%), from €982,430 to €1.0m
- Staff costs +€15,123
up €15,123 (+6.5%), from €233,122 to €248,245
- Taxes -€14,238
down €14,238 (-6.9%), from €205,768 to €191,530
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,476,785 | €1,829,525 | -€647,260 | -26.1% |
| Fixed assets | 21/28 | €14,845 | €11,445 | -€3,400 | -22.9% |
| Tangible fixed assets | 22/27 | €14,845 | €11,445 | -€3,400 | -22.9% |
| Plant, machinery and equipment | 23 | €14,845 | €11,445 | -€3,400 | -22.9% |
| Current assets | 29/58 | €2,461,940 | €1,818,080 | -€643,860 | -26.2% |
| Amounts receivable within one year | 40/41 | €28,833 | €281 | -€28,552 | -99.0% |
| Trade receivables | 40 | €24,119 | €281 | -€23,838 | -98.8% |
| Other amounts receivable | 41 | €4,714 | €0 | -€4,714 | -100.0% |
| Current investments | 50/53 | €0 | €1,237,330 | +€1.2m | |
| Cash at bank and in hand | 54/58 | €2,433,107 | €578,941 | -€1.9m | -76.2% |
| Deferred charges and accrued income | 490/1 | €0 | €1,527 | +€1,527 | |
| Total equity and liabilities | 10/49 | €2,476,785 | €1,829,525 | -€647,260 | -26.1% |
| Equity | 10/15 | €922,275 | €486,126 | -€436,149 | -47.3% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €822,275 | €386,126 | -€436,149 | -53.0% |
| Distributable reserves | 133 | €822,275 | €386,126 | -€436,149 | -53.0% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €1,554,510 | €1,343,399 | -€211,111 | -13.6% |
| Amounts payable within one year | 42/48 | €1,554,384 | €1,343,399 | -€210,985 | -13.6% |
| Trade debts | 44 | €51,417 | €39,058 | -€12,359 | -24.0% |
| Suppliers | 440/4 | €51,417 | €39,058 | -€12,359 | -24.0% |
| Taxes, remuneration and social security | 45 | €83,351 | €75,737 | -€7,614 | -9.1% |
| Taxes | 450/3 | €61,096 | €48,147 | -€12,949 | -21.2% |
| Remuneration and social security | 454/9 | €22,255 | €27,590 | +€5,335 | +24.0% |
| Other amounts payable | 47/48 | €1,419,616 | €1,228,604 | -€191,013 | -13.5% |
| Accrued charges and deferred income | 492/3 | €126 | €0 | -€126 | -100.0% |
| Remuneration, social security and pensions | 62 | €233,122 | €248,245 | +€15,123 | +6.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,155 | €3,400 | +€1,245 | +57.8% |
| Other operating charges | 640/8 | €2,519 | €3,969 | +€1,451 | +57.6% |
| Gross operating margin | 9900 | €982,430 | €1,004,935 | +€22,505 | +2.3% |
| Operating profit (loss) | 9901 | €744,635 | €749,321 | +€4,686 | +0.6% |
| Financial income | 75/76B | €72,013 | €11,630 | -€60,383 | -83.8% |
| Recurring financial income | 75 | €72,013 | €11,630 | -€60,383 | -83.8% |
| Financial charges | 65/66B | €12 | €4 | -€9 | -70.9% |
| Recurring financial charges | 65 | €12 | €4 | -€9 | -70.9% |
| Profit (loss) for the period before taxes | 9903 | €816,636 | €760,947 | -€55,688 | -6.8% |
| Income taxes | 67/77 | €205,768 | €191,530 | -€14,238 | -6.9% |
| Profit (loss) for the period | 9904 | €610,868 | €569,417 | -€41,451 | -6.8% |
| Profit (loss) for the period to be appropriated | 9905 | €610,868 | €569,417 | -€41,451 | -6.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.